Activatable zymography probes enable in situ localization of protease dysregulation in cancer
A. P. Soleimany, J. D. Kirkpatrick, S. Su, J. S. Dudani, Q. Zhong, A. Bekdemir, S. N. Bhatia
This paper introduces activatable zymography probes (AZPs) to detect protease activity in cancer tissues, demonstrating their utility in classifying disease and guiding therapeutic design.
bioRxiv · Jul 29, 2020Bioengineering